US 7846973
Chemical process and new crystalline form
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7846973 (Chemical process and new crystalline form) held by Theravance, Inc. expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P43/00